Evidence map›Paper›PMID 36982890›Full record

ArticleInternational journal of molecular sciences2023

Novel Rigidochromic and Anti-Kasha Dual Emission Fluorophores Based on D-π-A Dyads as the Promising Materials for Potential Applications Ranging from Optoelectronics and Optical Sensing to Biophotonics and Medicine.

Svetlana A Lermontova, Maxim V Arsenyev, Anton V Cherkasov, Georgy K Fukin, Andrey V Afanasyev, Andrey V Yudintsev, Ilya S Grigoryev, Elena Yu Ladilina, Tatyana S Lyubova, Natalia Yu Shilyagina and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Svetlana A LermontovaG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Maxim V ArsenyevG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.ORCID 0000-0001-5275-8241
Anton V CherkasovG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Georgy K FukinG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Andrey V AfanasyevInstitute of Applied Physics of RAS, 603950 Nizhny Novgorod, Russia.
Andrey V YudintsevBiological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0003-0333-5095
Ilya S GrigoryevG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Elena Yu LadilinaG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-9856-6250
Tatyana S LyubovaG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Natalia Yu ShilyaginaBiological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0001-5766-6880
Irina V BalalaevaBiological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-3245-3907
Larisa G KlapshinaG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.
Alexandr V PiskunovG.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-8200-9433
G.A. Razuvaev Institute of Organometallic Chemistry · RUN. I. Lobachevsky State University of Nizhny Novgorod · RUInstitute of Applied Physics · RU

Funding

Ministry of Science and Higher Education of the Russian Federation as part of the state assignment of the IAP RAS 0035-2019-0012Ministry of Science and Higher Education of the Russian Federation: UNN "Priority 2030" Strategic Academic Leadership Program H-417-99_2022-2023
6 · The paper itself

Abstract

Today we see an increasing demand for new fluorescent materials exhibiting various sensory abilities due to their broad applicability ranging from the construction of flexible devices to bioimaging. In this paper, we report on the new fluorescent pigments AntTCNE, PyrTCNE, and PerTCNE which consist of 3-5 fused aromatic rings substituted with tricyanoethylene fragments forming D-π-A diad. Our studies reveal that all three compounds exhibit pronounced rigidochromic properties, i.e., strong sensitivity of their fluorescence to the viscosity of the local environment. We also demonstrate that our new pigments belong to a very rare type of organic fluorophores which do not obey the well-known empirical Kasha'rule stating that photoluminescence transition always occurs from the lowest excited state of an emitting molecule. This rare spectral feature of our pigments is accompanied by an even rarer capability of spectrally and temporally well-resolved anti-Kasha dual emission (DE) from both higher and lowest electronic states in non-polar solvents. We show that among three new pigments, PerTCNE has significant potential as the medium-bandgap non-fullerene electron acceptor. Such materials are now highly demanded for indoor low-power electronics and portable devices for the Internet-of-Things. Additionally, we demonstrate that PyrTCNE has been successfully used as a structural unit in template assembling of the new cyanoarylporphyrazine framework with 4 D-π-A dyads framing this macrocycle (Pyr

Indexed as

Fluorescent DyesFluorescenceSolventsFluorescent DyesSolventsanti-Kasha fluorescencearyltricyanoethylenescyanoarylporphyrazinesdual emissionrigidochromism

Identifiers

PMID36982890
PMCPMC10057995
OpenAlexW4327966084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.